Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PSMA-targeted docetaxel conjugate with high antitumor activity and improved toxicity and solubility

Dec. 22, 2021

Histone-lysine N-methyltransferase 2A inhibitors discovered at Novartis

Dec. 22, 2021

RET inhibitor SYHA-1815 induces G1 cell cycle arrest through c-MYC downregulation

Dec. 22, 2021

P38 targeting reverses immunosuppressive tumor microenvironment in metastatic breast cancer

Dec. 21, 2021

Mouse model of metaplastic breast cancer with conditional overexpression of TRIM24

Dec. 21, 2021

MCC-1734 inhibits cancer cells with different resistance mechanisms

Dec. 21, 2021

IpY.20 targets p27Kip1 to evade breast cancer resistance driven by CDK4 and CDK2

Dec. 21, 2021

JAK inhibitors divulged by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical

Dec. 21, 2021

Biopolar Hongye presents new Janus kinase inhibitors

Dec. 21, 2021

GTPase KRAS mutant inhibitors patented by Genfleet Therapeutics

Dec. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...